Thursday, October 5, 2023
wellness India Expo
Home Tags Dr Kiran Mazumdar Shaw

Tag: Dr Kiran Mazumdar Shaw

Biocon Biologics announces positive CHMP opinion for its biosimilar to treat...

The CHMP positive opinion will be considered by the European Commission whose decision on the approval is expected by the end of September 2023

Biocon Academy holds graduation ceremony for 185 students

73% of graduating students are females; 100% placement achieved

Biocon awarded a Silver Medal by EcoVadis for its sustainability accomplishments

Overall Score of 66 puts Biocon in the 89th percentile in 2022 assessment

Biocon Biologics wins ‘ABEA : Bioprocessing Excellence in South Asia’ Award

The company garnered the maximum number of votes from among 70,000 biopharma professionals who participated in the survey

World Cancer Day: Dr Devi Shetty & Kiran Mazumdar Shaw inaugurate...

The unit will boost of CAR-T Cell Therapy & Immunotherapy and has proficient medical staff including of haemato-oncologists, BMT physicians and nursing staff.

Kiran Mazumdar Shaw leads investment in Shaili Chopra led uses technology to provide women with an intelligent dashboard, world class experts and personalized journeys for better health outcomes.

Mapmygenome launches Genomics Experience Center in Bengaluru

Customers get access to distinctive services such as genetic tests, genetic counseling, blood tests, health screening tests, antibody tests and COVID-19 RT-PCR tests

Pharma industry reiterates its commitment to US$ 130 billon by 2030

Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance

Biocon Biologics & Serum Institute Life Sciences announce strategic alliance

BBL will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets. SILS to receive ~15% stake in BBL at a post-money valuation of ~$4.9 billion......................

Advancements in digital technology critical to advancements in clinical trials

As per experts, the digital-enabled regulatory flexibility during the pandemic that had helped bring drugs faster to market needs to continue.....................